Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

July 2, 2013

Primary Completion Date

October 11, 2018

Study Completion Date

October 11, 2018

Conditions
Urinary Incontinence
Interventions
BIOLOGICAL

OnabotulinumtoxinA

OnabotulinumtoxinA injected into the detrusor wall on Day 1.

Trial Locations (31)

2650

UZ Antwerpen, Antwerp

3000

UZ Leuven, Leuven

6100

Ankara University Medical Faculty Cebeci Hospital, Ankara

9000

UZ Gent , Urology, Ghent

10591

Pediatric Urology Associates, PC, Tarrytown

27710

Duke University Health System, Durham

28207

McKay Urology Carolinas Medical Center, Charlotte

29425

Medical University of South Carolina, Charleston

33076

Hopital Pellegrin - Enfants, Bordeaux

35233

University of Alabama at Birmingham, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46032

Riley Hospital for Children, Indianapolis

48073

William Beaumont Hospital Research Institute, Royal Oak

50005

Fakultni nemocnice Hradec Kralove, Hradec Králové

53226

Children's Hospital of Wisconsin, Milwaukee

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63110

Washington University School of Medicine, St Louis

73104

Oklahoma Childrens Hospital, Oklahoma City

75012

Hopital Trousseau, Paris

75015

Necker Enfants Malades Hospital, Paris

77520

Fakultni nemocnice Olomouc, Olomouc

80138

Seconda Università di Napoli, Caserta

87000

CHU de Limoges - Hopital Mere et l'Enfant, Limoges

90048

Cedars-Sinai Medical Center, Los Angeles

92868

Children's Hospital of Orange County, Orange

L8N 3Z5

McMaster University Medical Centre, Hamilton

H3T 1C5

CHU Sainte-Justine, Montreal

00165

IRCCS Ospedale Pediatrico Bambino Gesu, Roma

80-803

Copernicus Podmiot Leczniczy Sp. z o. o., Kliniczny Oddzial Chirurgii i Urologii Dzieci i Mlodziezy GUMed, Gdansk

61-512

Specjalistyczny Gabinet Lekarski, Poznan

50-369

Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY